---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-044511"
form_type: "8-K"
ticker: "FNCHQ"
cik: "0001733257"
company_name: "Finch Therapeutics Group, Inc."
filed_at: "2024-02-23T23:59:59+00:00"
generated_at: "2026-06-05T17:13:40.896636+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Nasdaq says Finch is a 'public shell', seeks delisting; company appeals

## Summary
- Nasdaq notified Finch on Feb 16, 2024 that it believes the company is a public shell and continued listing is unwarranted.
- Finch disagrees and has requested an appeal hearing, which automatically stays any suspension or delisting pending the hearing.
- No assurance that the appeal will succeed or that Finch can maintain listing compliance.
- Patent litigation trial vs. Rebiotix/Ferring reset from May 20 to Aug 5, 2024.

## SEC filing metadata
- accession: 0001193125-24-044511
- form_type: 8-K
- ticker: FNCHQ
- cik: 0001733257
- company_name: Finch Therapeutics Group, Inc.
- filed_at: 2024-02-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1733257/000119312524044511/0001193125-24-044511-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1733257/000119312524044511/d788826d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-044511
- JSON: https://secwatch.observer/filing/0001193125-24-044511.json
- Plain text: https://secwatch.observer/filing/0001193125-24-044511.txt

## Key facts
- Listing & Compliance Notices
  Finch Therapeutics Group, Inc. received a nasdaq delisting notice notice regarding other (rules 5101).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Rules: 5101
  source text: February 16, 2024, Finch Therapeutics Group, Inc. (the “Company”) was notified by the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that, based on the Staff’s review of the Company and pursuant to Listing Rule 5101, the Staff believes that the Company no longer has an operating business and is a “public shell” and that the continued listing of its securities is no longer warranted. The Company disagrees with Nasdaq’s determination regarding the Company’s status as a “public shell” and, accordingly, has requested an appeal hearing. The hearing request
  evidence_url: https://www.sec.gov/Archives/edgar/data/1733257/000119312524044511/0001193125-24-044511-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.